GSI 704 (Truvada 133 mg / 200 mg)

Generic Name: emtricitabine/tenofovir

Pill imprint GSI 704 has been identified as Truvada 133 mg / 200 mg.

Truvada is used in the treatment of pre-exposure prophylaxis; hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Truvada 133 mg / 200 mg is not a controlled substance under the Controlled Substance Act (CSA).

Truvada

Generic Name:

emtricitabine/tenofovir

Imprint:

GSI 704

Strength:

133 mg / 200 mg

Color:

Blue

Shape:

Rectangle

Availability:

Prescription only

Drug Class:

Antiviral combinations

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Gilead Sciences, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.